Transfusion and Haematology Today - Issue 4/2017
185
Next generation sequencing in acute myeloid leukaemia: new insights into the pathogenesis and development of leukemic clones
M. Čulen, Z. Kosařová, I. Ježíšková, A. Folta, D. Dvořáková, L. Semerád, Z. Šustková, Z. Ráčil
192
Possible discontinuation of treatment by tyrosine kinase inhibitors in patients with chronic myeloid leukemia and concept of treatment-free remission
J. Šrámek, M. Karas, D. Lysák, P. Jindra
199
The first oral proteasome inhibitor in the treatment of relapsed/refractory multiple myeloma
H. Plonková, T. Jelínek, L. Szeligová, R. Hájek
210
Epigenetic changes as a novel tool for prognostic stratifying chronic lymphocytic leukaemia
L. Poppová, K. Plevová, Š. Pospíšilová
215
Angioimmunoblastic T-lymphoma: overview, single centre experience and case report of the sequential development of difuse large B-cell lymphoma
J. Michalka, A. Janíková, J. Soukup, M. Kalinová, L. Křen, Z. Král, M. Mayer
223
Transfusion and Haematology Today
2017 Issue 4
Most read in this issue
- Angioimmunoblastic T-lymphoma: overview, single centre experience and case report of the sequential development of difuse large B-cell lymphoma
- Next generation sequencing in acute myeloid leukaemia: new insights into the pathogenesis and development of leukemic clones
- Possible discontinuation of treatment by tyrosine kinase inhibitors in patients with chronic myeloid leukemia and concept of treatment-free remission
- The first oral proteasome inhibitor in the treatment of relapsed/refractory multiple myeloma